Suppr超能文献

成釉细胞瘤和牙源性角化囊肿中p53肿瘤抑制蛋白及Bcl-2家族蛋白(Bcl-2和Bax)的异常免疫表达

Aberrant immunoexpression of p53 tumour-suppressor and Bcl-2 family proteins (Bcl-2 and Bax) in ameloblastomas and odontogenic keratocysts.

作者信息

Escobar Enrico, Gómez-Valenzuela Fernán, Peñafiel Cristian, Chimenos-Küstner Eduardo, Pérez-Tomás Ricardo

机构信息

Department of Oral Pathology and Medicine, Faculty of Dentistry, University of Chile, Santiago, Chile.

Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.

出版信息

J Clin Exp Dent. 2023 Feb 1;15(2):e125-e134. doi: 10.4317/jced.59769. eCollection 2023 Feb.

Abstract

BACKGROUND

The growth of ameloblastomas (odontogenic tumours) and odontogenic keratocyst (OKC) (developmental cyst) is associated with the expression of proteins related to cell survival and apoptosis. Bcl-2-associated protein X (Bax) and the tumour suppressor protein p53 collectively promote p53-mediated apoptosis. This study aimed to assess the immunohistochemical expression of p53, Bcl-2 and Bax in conventional ameloblastoma (CA), unicystic ameloblastoma (UA) types, and OKC sporadic (OKC-NS/S) and syndromic (OKC-NBSCC).

MATERIAL AND METHODS

Paraffinized blocks of CA (n=18), UA (n=15), OKC-NS/S (n=18) and OKC-NBSCC (n=15) fixed in 10% formalin were used. After diagnosis, tissue specimens were stained by immunohistochemistry for p53, Bcl-2 and Bax marker. Stained cells were randomly counted in five high power fields. The data analysis was performed via Shapiro-Wilk test, ANOVA with Tukey's multiple comparisons or Kruskal-Wallis with Dunn's multiple comparisons. Statistical significance was defined as <0.05.

RESULTS

We did not observe differences between p53 expression in CA, mural UA (MUA), intraluminal/luminal UA (I/LUA), OKC-NS/S, and OKC-NBSCC (19.69%, 18.74%, 16.76%, 12.35% and 9.04%, respectively). Similar results were recognized for Bax expression in CA, MUA, I/LUA, OKC-NS/S, and OKC-NBSCC (33.72%, 34.95%, 22.94, 21.58% and 20.76%, respectively). However, we recognized significant differences between Bcl-2 expression in OKC-NS/S vs MUA, OKC-NS/S vs I/LUA, OKC-NS/S vs CA, OKC-NBSCC vs MUA, OKC-NBSCC vs I/LUA, and I/LUA vs CA. P53, Bcl-2 and Bax levels were higher in mural morphological areas versus intraluminal and luminal morphological areas in UA.

CONCLUSIONS

There is a tendency for an increased expression of p53, Bcl-2, and Bax proteins in CA, and mural proliferation of UA, compared to lesions with a cystic morphology, which could be associated with a local aggressive behaviour. p53, Bcl-2, Bax protein, apoptosis, odontogenic tumour, odontogenic cyst.

摘要

背景

成釉细胞瘤(牙源性肿瘤)和牙源性角化囊肿(OKC,发育性囊肿)的生长与细胞存活和凋亡相关蛋白的表达有关。Bcl-2相关蛋白X(Bax)和肿瘤抑制蛋白p53共同促进p53介导的凋亡。本研究旨在评估p53、Bcl-2和Bax在传统型成釉细胞瘤(CA)、单囊性成釉细胞瘤(UA)、散发性OKC(OKC-NS/S)和综合征性OKC(OKC-NBSCC)中的免疫组化表达。

材料与方法

使用固定于10%福尔马林中的CA(n=18)、UA(n=15)、OKC-NS/S(n=18)和OKC-NBSCC(n=15)的石蜡块。诊断后,组织标本通过免疫组化检测p53、Bcl-2和Bax标记物。在五个高倍视野中随机计数染色细胞。数据分析通过Shapiro-Wilk检验、Tukey多重比较的方差分析或Dunn多重比较的Kruskal-Wallis检验进行。统计学显著性定义为<0.05。

结果

我们未观察到CA、壁性UA(MUA)、腔内/管腔内UA(I/LUA)、OKC-NS/S和OKC-NBSCC中p53表达的差异(分别为19.69%、18.74%、16.76%、12.35%和9.04%)。CA、MUA、I/LUA、OKC-NS/S和OKC-NBSCC中Bax表达也得到类似结果(分别为33.72%、34.95%、22.94%、21.58%和20.76%)。然而,我们发现OKC-NS/S与MUA、OKC-NS/S与I/LUA、OKC-NS/S与CA、OKC-NBSCC与MUA、OKC-NBSCC与I/LUA以及I/LUA与CA之间Bcl-2表达存在显著差异。UA中壁性形态区域的p53、Bcl-2和Bax水平高于腔内和管腔内形态区域。

结论

与具有囊性形态的病变相比,CA和UA的壁性增殖中p53、Bcl-2和Bax蛋白表达有增加的趋势,这可能与局部侵袭性行为有关。p53、Bcl-2、Bax蛋白、凋亡、牙源性肿瘤、牙源性囊肿。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b33e/9994657/30844b90dacc/jced-15-e125-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验